Work

A Phase 2a/2b Multicenter Study of AG-946 in Patients with Anemia Due to Lower-Risk Myelodysplastic Syndromes

Year: 2022

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2022-168907

Authors: Hanny Al-Samkari, Pierre Fenaux, Mikkael A. Sekeres, Eytan Stein, David A. Sallman, Andrew M. Brunner, Xiaoshu D. Gurov, Ophelia Yin, Meghan Frisbie, James Xiao, Joy Bhatia, Vanessa Beynon, Megan Wind-Rotolo, Melissa Dibacco, Uwe Platzbecker

Institutions: Harvard University, Massachusetts General Hospital, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, University of Miami, Sylvester Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Moffitt Cancer Center, Agios Pharmaceuticals (United States), University Hospital Leipzig

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310106421

FWCI: 0.78

Cites:

Cited by: 6

Related to: 10